Prothena | PRTA - 貿易債権者





貿易債権者 変化する 日付
Acadia Pharmaceuticals USD 16.33M 28.24M 2026-09
Agios Pharmaceuticals USD 19.93M 3.58M 2026-09
Akebia Therapeutics USD 7.61M 1.81M 2026-09
ALKERMES USD 107.69M 35.17M 2026-09
Alnylam Pharmaceuticals USD 135.4M 27.38M 2026-09
Amgen USD 20.83B 17.97B 2026-09
Biogen USD 430.3M 26.4M 2026-09
BioMarin Pharmaceutical USD 946.11M 32.44M 2026-09
Exelixis USD 30.83M 8.23M 2026-09
Immunic USD 11.01M 873K 2026-03
Incyte USD 235.37M 1.16B 2026-09
Ionis Pharmaceuticals USD 27.11M 20.59M 2026-09
MacroGenics USD 3.44M 845K 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Prothena USD 1.69M 249K 2026-09
Regeneron Pharmaceuticals USD 1.14B 19M 2026-09
Ultragenyx Pharmaceutical USD 45M 6M 2026-09
Vertex Pharmaceuticals USD 3.71B 99.2M 2026-09